MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Carcinosarcoma

(UMLS:C0007140)

Definition:: A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. (Stedman, 25th ed)
UMLS ID:: C0007140
MeSH ID:: D002296

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.435.290|C04.557.450.795.290

Synonym(s)

Carcinosarcoma

CARCINOSARCOMA, MALIGNANT

Carcinosarcoma NOS

Carcinosarcoma, NOS

carcinosarcoma

carcinosarcomas

Associated Drug(s)

	Name	Reference(s)	Data Source
1	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	15132766	CTD
2	Cyclophosphamide	346364	CTD
3	Quercetin	21362404	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Chondrosarcoma	50.4%
2	leiomyosarcoma	50.4%
3	liposarcoma	50.4%
4	synovial sarcoma	50.4%
5	Clear Cell Sarcoma of Soft Tissue	50.4%
6	Alveolar Soft Part Sarcoma	50.4%
7	Hemangiosarcoma	49.2%
8	lymphangiosarcoma	49.2%
9	Fibrosarcoma	46.2%
10	Osteosarcoma	46.2%
11	Malignant Fibrous Histiocytoma	44%
12	Sarcoma, Myeloid	43.9%
13	Phyllodes Tumor	42.4%
14	Desmoplastic Small Round Cell Tumor	42.4%
15	Mesenchymoma	40.7%
16	Hepatoblastoma	40.7%
17	Mixed Tumor, Mullerian	40.7%
18	Rhabdomyosarcoma	38.7%
19	Angiomyolipoma	37.4%
20	leukemia	37.1%
21	Neoplasms, Germ Cell and Embryonal	37.1%
22	Neoplasms, Glandular and Epithelial	37.1%
23	Germ Cell Cancer	37.1%
24	Dermatofibrosarcoma	36.6%
25	Dermatofibrosarcoma Protuberans	36.6%
26	Endometrial Stromal Sarcoma	36%
27	Neuroectodermal Tumors	34.7%
28	Neoplasms, Neuroepithelial	33.3%
29	Gliomatosis cerebri	33.3%
30	Sarcoma, Experimental	33.1%
31	Alveolar rhabdomyosarcoma	32.9%
32	Composite Lymphoma	31.7%
33	Sarcoma 180	30.2%
34	melanoma	29.2%
35	Giant Cell Tumor of Bone	29%
36	Histiocytic Disorders, Malignant	27.7%
37	Thymoma	27.6%
38	Medulloblastoma	26.3%
39	Neurofibrosarcoma	26.3%
40	Adenoma, Acidophil	25.2%
41	Ganglioneuroma	25.2%
42	Glioma	25.2%
43	Malignant Glioma	25.2%
44	Meningioma	25.1%
45	Lipoma	25%
46	Myoma	25%
47	Myxoma	25%
48	Angiolipoma	25%
49	Myelolipoma	25%
50	Neoplasms, Bone Tissue	25%
51	Neoplasms, Fibrous Tissue	25%
52	Smooth Muscle Tumor	25%
53	Chondroma	25%
54	Enchondroma	25%
55	Adenofibroma	24.6%
56	Fibroadenoma	24.6%
57	Basal cell carcinoma	24.4%
58	Carcinoma, Papillary	24.4%
59	Squamous cell carcinoma	24.4%
60	Craniopharyngioma	24.4%
61	Cystadenoma	24.4%
62	Mesothelioma	24.4%
63	Neuroectodermal Tumor, Melanotic	24.4%
64	Neuroendocrine Tumors	24.4%
65	Carcinoma, Basal Cell	24.4%
66	Leukemia, Plasma Cell	23.5%
67	Carcinoid Tumor	23.2%
68	Neurilemmoma	23.2%
69	Hutchinson's Melanotic Freckle	23.2%
70	Melanoma, Amelanotic	23.2%
71	Adenoma	23.1%
72	Ameloblastoma	23.1%
73	Angiokeratoma	23.1%
74	Carcinoma	23.1%
75	Chordoma	23.1%
76	Hemangioma	23.1%
77	hemangiopericytoma	23.1%
78	Lymphangioma	23.1%
79	Nevus	23.1%
80	Teratoma	23.1%
81	Germinoma	23.1%
82	Teratocarcinoma	23.1%
83	Angiofibroma	23.1%
84	Epithelioma	23.1%
85	Hamartoma	22.4%
86	Neoplasms, Hormone-Dependent	22.4%
87	Neoplasms, Multiple Primary	22.4%
88	Paraneoplastic Syndromes	22.4%
89	Precancerous Conditions	22.4%
90	Neoplasms, Second Primary	22.4%
91	Lymphoma	22.1%
92	Melanoma, Experimental	21.9%
93	Cystadenocarcinoma	21.9%
94	Mucoepidermoid Carcinoma	21.9%
95	Carcinoma, Ehrlich Tumor	21.7%
96	Dermoid Cyst	21.7%
97	Carcinoma, Lewis Lung	21.7%
98	Trophoblastic Neoplasms	21.5%
99	Leukemia, Experimental	21.3%
100	Astrocytoma	21.2%
101	Ependymoma	21.2%
102	oligodendroglioma	21.2%
103	Ganglioglioma	21.2%
104	gliosarcoma	21.2%
105	Anaplastic astrocytoma	21.2%
106	Anaplastic Oligodendroglioma	21.2%
107	Lymphangioleiomyomatosis	20.5%
108	Malignant Carcinoid Syndrome	20.2%
109	fibroma	19.5%
110	Fibromatosis	19.5%
111	Osteoblastoma	19.5%
112	Osteoma	19.5%
113	Rhabdomyoma	19.5%
114	Chondromatosis	19.5%
115	Bowen's Disease	19.4%
116	Paraganglioma	19.4%
117	Glioblastoma	19.2%
118	Neuroblastoma	19.2%
119	Glioblastoma Multiforme	19.2%
120	Choriocarcinoma	18.4%
121	Carcinoma, Lobular	18.4%
122	Ganglioneuroblastoma	18.2%
123	Leukemia L1210	18%
124	Leukemia P388	18%
125	Acanthoma	18%
126	Leukemia, Radiation-Induced	18%
127	Plasmacytoma	17.4%
128	Malignant histiocytosis	17.2%
129	Histiocytic sarcoma	17.2%
130	Nephroblastoma	17%
131	Pheochromocytoma	16.9%
132	Cyst	16.8%
133	Neoplastic Processes	16.8%
134	Neoplastic Syndromes, Hereditary	16.8%
135	Pregnancy Complications, Neoplastic	16.8%
136	Fibromatosis, Aggressive	16.7%
137	Fibromatosis, Abdominal	16.7%
138	Mesoblastic Nephroma	16.6%
139	Neoplasms, Experimental	16.5%
140	Adenocarcinoma	16.3%
141	Carcinoma in Situ	16.3%
142	Carcinoma, Transitional Cell	16.3%
143	Dysgerminoma	16.3%
144	Hemangioendothelioma	16.3%
145	Neuroma	16.3%
146	Papilloma	16.3%
147	Pseudomyxoma Peritonei	16.3%
148	Seminoma	16.3%
149	Papillomatosis	16.3%
150	Adenomatosis, Pulmonary	16.3%
151	Adenomatous Polyps	16.3%
152	Carcinoma, Large Cell	16.3%
153	Carcinoma, Small Cell	16.3%
154	Carcinoma 256, Walker	16.2%
155	Retinoblastoma	16.1%
156	Carcinoid Heart Disease	15.8%
157	Mastocytosis	15.3%
158	Gastrointestinal Stromal Tumors	15.1%
159	Carcinosarcoma	14.8%
160	Mastocytoma	14.7%
161	Mastocytosis, Systemic	14.6%
162	Multiple Endocrine Neoplasia	14.1%
163	Hodgkin Disease	13.7%
164	Lymphoma, Non-Hodgkin	13.7%
165	Neoplasms, Radiation-Induced	13.2%
166	Sarcoma	13.2%
167	Adenoid Cystic Carcinoma	13%
168	Adenocarcinoma, Clear Cell	13%
169	Cholangiocarcinoma	13%
170	Cervical Intraepithelial Neoplasia	13%
171	Hemangioblastoma	13%
172	Lymphoma, Extranodal NK-T-Cell	13%
173	Lymphomatoid Granulomatosis	12.5%
174	Abdominal Neoplasms	12.4%
175	Erythroplasia	12.4%
176	Follicular cyst	12.4%
177	Head and Neck Neoplasms	12.4%
178	Mucocele	12.4%
179	Pilonidal Cyst	12.4%
180	Soft Tissue Neoplasms	12.4%
181	Thoracic Neoplasms	12.4%
182	Thyroglossal Cyst	12.4%
183	Synovial Cyst	12.4%
184	Aberrant Crypt Foci	12.4%
185	Paraneoplastic Encephalomyelitis	12.2%
186	Leukemia, Myelomonocytic, Chronic	12.2%
187	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	12.2%
188	Mammary Neoplasms, Experimental	12%
189	Acoustic Neuroma	12%
190	Carcinoma, Pancreatic Ductal	11.8%
191	Basal Cell Nevus Syndrome	11.6%
192	Primary amyloidosis	11.5%
193	Klatskin Tumor	11.3%
194	Hydatidiform Mole	11%
195	Hepatocellular Adenoma	10.9%
196	Optic Nerve Glioma	10.8%
197	Vipoma	10.3%
198	Dupuytren Contracture	10.3%
199	Tuberous Sclerosis	10.1%
200	Urticaria Pigmentosa	10.1%
201	Sturge-Weber Syndrome	10%
202	Hemangioma, Cavernous	9.8%
203	Leukemia, T-Cell	9.7%
204	Leukemia, B-Cell	9.7%
205	Digestive System Neoplasms	9.7%
206	Endocrine Gland Neoplasms	9.7%
207	Eye Neoplasms	9.7%
208	Nervous System Neoplasms	9.7%
209	neurofibroma	9.7%
210	Leukemia, Myeloid, Chronic-Phase	9.7%
211	Lymphoma, Follicular	9.7%
212	T-Cell Lymphoma	9.7%
213	Mantle cell lymphoma	9.7%
214	Bone neoplasms	9.4%
215	Leukoplakia	9.4%
216	Lymphocele	9.4%
217	Pancreatic Cyst	9.4%
218	Skin Neoplasms	9.4%
219	Hematologic Neoplasms	9.4%
220	Prolactinoma	9.3%
221	Growth Hormone-Secreting Pituitary Adenoma	9.3%
222	Barrett Esophagus	9.2%
223	Breast Cyst	9.2%
224	Actinic keratosis	9.2%
225	Mediastinal Cyst	9.2%
226	Neoplasm Invasiveness	9.2%
227	Neoplasm Metastasis	9.2%
228	Neoplasm Recurrence, Local	9.2%
229	Parovarian Cyst	9.2%
230	Pericardial Cyst	9.2%
231	Splenic Neoplasms	9.2%
232	Thymic Cyst	9.2%
233	Carcinogenesis	9.2%
234	Myxoid cyst	9.2%
235	Metastasis	9.2%
236	Multiple Endocrine Neoplasia Type 1	8.9%
237	Waldenstrom Macroglobulinemia	8.6%
238	Multiple Myeloma	8.6%
239	Denys-Drash Syndrome	8.6%
240	granulosa cell tumor	8.1%
241	Carcinoma, Ovarian Epithelial	8.1%
242	insulinoma	8%
243	Parathyroid Neoplasms	7.9%
244	Peritoneal Neoplasms	7.9%
245	Thyroid Neoplasm	7.9%
246	Thyroid carcinoma	7.9%
247	Adenomatous Polyposis Coli	7.8%
248	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	7.7%
249	Leukemia, Large Granular Lymphocytic	7.7%
250	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	7.7%
251	Retroperitoneal Neoplasms	7.7%
252	Lymphoma, T-Cell, Cutaneous	7.7%
253	Lymphoma, AIDS-Related	7.7%
254	Enteropathy-Associated T-Cell Lymphoma	7.7%
255	Primary Effusion Lymphoma	7.7%
256	Liver Neoplasms, Experimental	7.6%
257	Gastrinoma	7.4%
258	Glucagonoma	7.4%
259	Adrenocortical carcinoma	7.4%
260	Corpus Luteum Cyst	7.3%
261	Ovarian Cysts	7.3%
262	Leydig Cell Tumor	6.9%
263	Pancreatic Neoplasm	6.8%
264	Tracheal Neoplasms	6.7%
265	Mycosis Fungoides	6.7%
266	Lymphomatoid Papulosis	6.7%
267	Plasmablastic lymphoma	6.7%
268	Nasopharyngeal carcinoma	6.6%
269	Leukoplakia, Oral	6.6%
270	Paraneoplastic Cerebellar Degeneration	6.6%
271	Renal Cell Carcinoma	6.4%
272	Papillary Renal Cell Carcinoma	6.4%
273	Choledochal Cyst	6.2%
274	Carcinoma, Endometrioid	6.2%
275	Peutz-Jeghers Syndrome	6.1%
276	Mouth Neoplasms	5.9%
277	Central Nervous System Neoplasms	5.9%
278	Vascular Neoplasms	5.9%
279	Thymus Neoplasms	5.9%
280	Genital Neoplasms, Female	5.8%
281	Pancreatic Pseudocyst	5.8%
282	Lymphatic Metastasis	5.7%
283	Neoplasms, Unknown Primary	5.7%
284	Leukemic Infiltration	5.7%
285	Breast Neoplasms, Male	5.7%
286	Neoplasm Micrometastasis	5.7%
287	Triple Negative Breast Neoplasms	5.7%
288	Esophageal Neoplasms	5.7%
289	Limbic Encephalitis	5.6%
290	Burkitt Lymphoma	5.5%
291	Thyroid Nodule	5.5%
292	Lambert-Eaton Myasthenic Syndrome	5%
293	Testicular Neoplasms	5%
294	Sezary Syndrome	4.8%
295	Adrenal Gland Neoplasms	4.8%
296	Gastrointestinal Neoplasms	4.8%
297	Genital Neoplasms, Male	4.8%
298	Liver neoplasms	4.8%
299	Uveal Neoplasms	4.8%
300	Urologic Neoplasms	4.7%
301	Sebaceous Gland Neoplasms	4.6%
302	Spinal Neoplasms	4.6%
303	Bone Marrow Neoplasms	4.6%
304	Polycystic Ovary Syndrome	4.6%
305	Opsoclonus-Myoclonus Syndrome	4.4%
306	Meningeal Neoplasms	4.1%
307	Myelitis, Transverse	3.9%
308	Nose Neoplasms	3.8%
309	Xeroderma Pigmentosum	3.7%
310	Palatal Neoplasms	3.7%
311	Ear Neoplasms	3.4%
312	Eyelid Neoplasms	3.4%
313	Lung Neoplasms	3.4%
314	Pleural Neoplasms	3.4%
315	Pituitary Adenoma	3.4%
316	Pituitary Neoplasms	3.4%
317	ovarian neoplasm	3.3%
318	Cell Transformation, Viral	3.3%
319	Brain Neoplasms	3.3%
320	Salivary Gland Neoplasms	3.3%
321	Spinal Cord Neoplasms	3.3%
322	Tongue Neoplasms	3.3%
323	Uterine Neoplasms	3.2%
324	Vaginal Neoplasms	3.2%
325	Vulvar Neoplasms	3.2%
326	Uterine Cancer	3.2%
327	Meningeal Carcinomatosis	3.2%
328	Fallopian Tube Neoplasms	3.2%
329	Pharyngeal Neoplasms	2.8%
330	Central Nervous System Cysts	2.8%
331	Bile Duct Neoplasms	2.7%
332	gallbladder neoplasm	2.7%
333	Intestinal Neoplasms	2.7%
334	Penile Neoplasms	2.7%
335	Prostatic Neoplasms	2.7%
336	Stomach Neoplasms	2.7%
337	Polycythemia Vera	2.7%
338	Bronchial Neoplasms	2.7%
339	Multiple Pulmonary Nodules	2.6%
340	Supratentorial Neoplasms	2.6%
341	Endometrial Neoplasms	2.6%
342	Zollinger-Ellison syndrome	2.6%
343	Laryngeal neoplasm	2.5%
344	Bladder Neoplasm	2.3%
345	Kidney Neoplasm	2.3%
346	Ureteral Neoplasms	2.3%
347	Urethral Neoplasms	2.3%
348	Brain Stem Neoplasms	2.2%
349	Hypopharyngeal Neoplasms	2.2%
350	Pleural Effusion, Malignant	2.2%
351	Hypopharyngeal Cancer	2.2%
352	Parotid Neoplasms	2.2%
353	Prostatic Neoplasms, Castration-Resistant	2.2%
354	Nelson Syndrome	2.1%
355	Choroid Plexus Papilloma	2.1%
356	Tonsillar Neoplasms	1.9%
357	Cerebellar Neoplasms	1.9%
358	Cecal Neoplasms	1.8%
359	Duodenal Neoplasms	1.8%
360	Nasopharyngeal Neoplasms	1.6%
361	Colorectal Neoplasms	1.6%
362	Radicular Cyst	1.6%
363	Appendiceal Neoplasms	1.6%
364	Colonic Neoplasms	1.6%
365	Rectal Neoplasms	1.6%
366	Paranasal Sinus Neoplasms	1.5%
367	Anus Neoplasms	1.3%
368	Sigmoid Neoplasms	1.3%
369	Maxillary Sinus Neoplasms	1.3%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234